Cristina Varas - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Cristina Varas

Showing results (21-30 of 30) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 30 results.

Clinical Epidemiology|October 23, 2014

Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa Scale and the RTI item bankAndrea V Margulis, Manel Pladevall, Nuria Riera-Guardia, et al.

European Journal of Clinical Pharmacology|November 15, 2017

Comparison of cardiovascular events among treatments for overactive bladder: a Danish nationwide cohort studyAndrea V Margulis, Jesper Hallas, Anton Pottegård, et al.

Circulation. Cardiovascular Quality and Outcomes|December 25, 2009

Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart diseaseWayne A Ray, Cristina Varas-Lorenzo, Cecilia P Chung, et al.

Pharmacotherapy|May 4, 2018

Variation in Cardiovascular Risk Related to Individual Antimuscarinic Drugs Used to Treat Overactive Bladder: A UK Cohort StudyAlejandro Arana, Andrea V Margulis, Lisa J McQuay, et al.

Pharmacoepidemiology and Drug Safety|March 24, 2018

Methodological challenges when evaluating potential off-label prescribing of drugs using electronic health care databases: A case study of dabigatran etexilate in EuropeMiguel Cainzos-Achirica, Cristina Varas-Lorenzo, Anton Pottegård, et al.

Pharmacoepidemiology and Drug Safety|October 22, 2020

Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United KingdomAlejandro Arana, Andrea V Margulis, Cristina Varas-Lorenzo, et al.

Plos One|September 20, 2018

Risk of ischemic stroke and the use of individual non-steroidal anti-inflammatory drugs: A multi-country European database study within the SOS ProjectTania Schink, Bianca Kollhorst, Cristina Varas Lorenzo, et al.

Pharmacoepidemiology and Drug Safety|January 31, 2017

Characterization of new users of cilostazol in the UK, Spain, Sweden, and GermanyJordi Castellsague, Susana Perez-Gutthann, Brian Calingaert, et al.

BMJ (Clinical Research Ed.)|September 30, 2016

Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control studyAndrea Arfè, Lorenza Scotti, Cristina Varas-Lorenzo, et al.

Plos One|November 2, 2018

Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS projectGwen M C Masclee, Huub Straatman, Andrea Arfè, et al.

Pageof 3

Search research articles

Showing results (21-30 of 30) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 30 results.

Clinical Epidemiology|October 23, 2014

European Journal of Clinical Pharmacology|November 15, 2017

Comparison of cardiovascular events among treatments for overactive bladder: a Danish nationwide cohort studyAndrea V Margulis, Jesper Hallas, Anton Pottegård, et al.

Circulation. Cardiovascular Quality and Outcomes|December 25, 2009

Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart diseaseWayne A Ray, Cristina Varas-Lorenzo, Cecilia P Chung, et al.

Pharmacotherapy|May 4, 2018

Variation in Cardiovascular Risk Related to Individual Antimuscarinic Drugs Used to Treat Overactive Bladder: A UK Cohort StudyAlejandro Arana, Andrea V Margulis, Lisa J McQuay, et al.

Pharmacoepidemiology and Drug Safety|March 24, 2018

Pharmacoepidemiology and Drug Safety|October 22, 2020

Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United KingdomAlejandro Arana, Andrea V Margulis, Cristina Varas-Lorenzo, et al.

Plos One|September 20, 2018

Pharmacoepidemiology and Drug Safety|January 31, 2017

Characterization of new users of cilostazol in the UK, Spain, Sweden, and GermanyJordi Castellsague, Susana Perez-Gutthann, Brian Calingaert, et al.

BMJ (Clinical Research Ed.)|September 30, 2016

Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control studyAndrea Arfè, Lorenza Scotti, Cristina Varas-Lorenzo, et al.

Plos One|November 2, 2018

Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS projectGwen M C Masclee, Huub Straatman, Andrea Arfè, et al.

Pageof 3